Initial results from the Southwest Oncology Group (SWOG) phase 3 RxPONDER trial demonstrate that postmenopausal women with a common form of breast cancer may be able to forego chemotherapy — and its potential adverse effects — in favor of standalone hormone therapy.
Ongoing research offers new promise for patients with metastasized, castration-resistant prostate cancer.
Type 1 diabetes has been known as an irreversible condition that no one can fully prevent. But now, several breakthrough studies have emerged that show prevention and management for the illness are possible.
A New Combination Therapy for HER2-Positive Metastatic Breast Cancer
The recent FDA approval of the drug Tukysa (tucatinib) for use with the chemotherapeutic agents trastuzumab and capecitabine provides a new treatment option to certain adults with HER2-positive breast cancer.
An FDA-approved drug cocktail may provide improvement for many patients with this common hereditary disease.
The health effects of coffee are not a novel field of research. A study in Comprehensive Reviews in Food Science and Food Safety in 2016 determined that the benefits of moderate coffee consumption among adults clearly outweigh its risks, and numerous studies have evaluated its possible neuroprotective effects.
The immunoglobulin E-blocking drug omalizumab limited the risk of adverse effects associated with oral immunotherapy (OIT) and increased OIT’s overall efficacy in participants with multiple food allergies, a phase 2 clinical trial at Stanford University found.
Electroconvulsive therapy (ECT) yields remission rates of close to 70 percent for clinically depressed patients who have not responded to antidepressants. However, it can cause side effects, including confusion and retrograde amnesia.
Fecal microbiota transplantation (FMT) via nasogastric feeding tube (NGT) is a cheaper yet similarly effective treatment method for recurrent Clostridium difficile infection (CDI) in children when compared with FMT via colonoscopy or nasoduodenal tube, a study from Children’s Hospital Colorado has found.
The use of statins for primary cardiovascular disease prevention in adults over age 75 is clouded in uncertainty. A recent study in the Journal of the American Geriatrics Society found that statins may significantly lower mortality risk in older adults. That only underscores the need for a large-scale, prospective, randomized clinical trial, researchers say.
- 1 of 6
- next ›